Back to 
Bank of Montreal
Bank of Montreal
NTLA
15 quarters
Position history for Bank of Montreal's holdings in Intellia Therapeutics, Inc.
No. Bank of Montreal exited its NTLA (Intellia Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 35,586 shares worth $414,933. Bank of Montreal already held NTLA in its Q4 2020 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$630,000
Total Shares Change
-8,656
Quarter-by-Quarter History
Other major holders of NTLA: ARK Investment Management LLC